These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9711972)

  • 61. Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.
    Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
    Neurology; 1998 Feb; 50(2):573-4. PubMed ID: 9484410
    [No Abstract]   [Full Text] [Related]  

  • 62. [Parkinson disease. Directed use of modern therapy].
    Möller JC; Wächter T; Oertel WH
    MMW Fortschr Med; 2001 May; 143 Suppl 2():45-50. PubMed ID: 11434257
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Occurrence of Takotsubo syndrome in a patient with Parkinson's disease after entacapone add-on.
    Baldacci F; Vergallo A; Del Dotto P; Ulivi M; Palombo C; Casolo G; Tomei G; Bonuccelli U
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1313-4. PubMed ID: 25258328
    [No Abstract]   [Full Text] [Related]  

  • 64. Parkinson's disease.
    Clarke CE; Moore AP
    Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619
    [No Abstract]   [Full Text] [Related]  

  • 65. [ What drug strategies are advisable for patients with advanced-stage Parkinson's].
    Brefel-Courbon C
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():120-59. PubMed ID: 10916046
    [No Abstract]   [Full Text] [Related]  

  • 66. Parkinson's: not easy to detect.
    Pountney D
    Nurs Older People; 2007 Jul; 19(6):12-3. PubMed ID: 17760362
    [No Abstract]   [Full Text] [Related]  

  • 67. [The prevalence of idiopathic Parkinson's disease].
    Giroud-Benítez JL
    Rev Neurol; 2001 Oct 1-15; 33(7):700. PubMed ID: 11784961
    [No Abstract]   [Full Text] [Related]  

  • 68. Cannabidiol in Parkinson's disease.
    Rieder CR
    Braz J Psychiatry; 2020 Apr; 42(2):126-127. PubMed ID: 32187321
    [No Abstract]   [Full Text] [Related]  

  • 69. Objective assessment in Parkinson's disease: optoelectronic movement and force analysis in clinical routine and research.
    Ingvarsson PE; Johnels B; Steg G; Olsson T
    Adv Neurol; 1999; 80():447-58. PubMed ID: 10410755
    [No Abstract]   [Full Text] [Related]  

  • 70. [Parkinson's disease. Physiopathology, diagnosis, evolution, treatment].
    Vidailhet M
    Rev Prat; 1999 Nov; 49(17):1915-21. PubMed ID: 10598511
    [No Abstract]   [Full Text] [Related]  

  • 71. PET studies and physiopathology of motor fluctuations in Parkinson's disease.
    Linazasoro G; Leenders KL
    Brain; 2004 Aug; 127(Pt 8):E15; author reply E16. PubMed ID: 15277309
    [No Abstract]   [Full Text] [Related]  

  • 72. [Current strategies for the treatment of Parkinson's disease].
    Wolters A; Benecke R
    MMW Fortschr Med; 2012 Apr; 154(7):59-62. PubMed ID: 22558877
    [No Abstract]   [Full Text] [Related]  

  • 73. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The future challenges in Parkinson's disease.
    Barker RA; Foltynie T
    J Neurol; 2004 Mar; 251(3):361-5. PubMed ID: 15015024
    [No Abstract]   [Full Text] [Related]  

  • 75. Parkinson's disease: clinical and therapeutic aspects.
    Heafield MT; Williams AC
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):288-94. PubMed ID: 1623254
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analyzer workshop on the treatment of Parkinson's disease.
    Mizuno Y; Yanagisawa N
    Eur Neurol; 1997; 38 Suppl 1():44-57. PubMed ID: 9276201
    [No Abstract]   [Full Text] [Related]  

  • 77. Recent advances in the treatment of Parkinson's disease.
    Martocci RJ
    J Am Osteopath Assoc; 1975 Apr; 74(8):730-41. PubMed ID: 1092751
    [No Abstract]   [Full Text] [Related]  

  • 78. Novel insights in pharmacogenetics of drug response in Parkinson's disease.
    Arbouw ME; Guchelaar HJ; Egberts TC
    Pharmacogenomics; 2010 Feb; 11(2):127-9. PubMed ID: 20136351
    [No Abstract]   [Full Text] [Related]  

  • 79. [Pharmacotherapy of a geriatric patient with Parkinson's disease].
    Klemmer JM; Schmitz S; Roth S; Simons S; Reineking N; Eisert A; Lang B; Jaehde U
    Med Monatsschr Pharm; 2007 Nov; 30(11):411-4. PubMed ID: 18062332
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Two-hundred Years Later: Is Parkinson's Disease a Single Defined Entity?
    Rodríguez-Violante M; Cervantes-Arriaga A; Fahn S; Tolosa E
    Rev Invest Clin; 2017; 69(6):308-313. PubMed ID: 29265118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.